Skip to content

A study to find the difference in bioavailability of 3 different ingredients through FenuMAT delivery system and its comparison with natural existing forms.

A double Blind , Placebo controlled Clinical study to evaluate the Bio availability of food garde formulaions (CurQred, BosFen,Resveratrol)of natural extracts emplyoing advanced FenuMAT delivery system

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/03/012753
Enrollment
45
Registered
2018-03-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: CurQred: Oral administration of a Single 500mg capsule on the dosing day. Intervention2: BosFen: Oral administration of a Single 500mg capsule on the dosing day. Intervention3: Bio avai

Sponsors

Akay Flavours and Aromatics Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy male and female volunteers 2. Subjects who are currnetly not under longterm medications. 3. Subjects who are willing to provide a written informed consent and comply with the protocol requirements.

Exclusion criteria

Exclusion criteria: 1. Subject who received any ingredients of formulations under study in last 48 hours. 2. Known Hypersensitivity to Herbal formulations. 3. Subjects who have particpated in any clinical study in within last one month. 4. pregnant or lactating women. 5. Any other condition that in the opinion of the investigator that does not justify the subjectâ??s participation in the trial

Design outcomes

Primary

MeasureTime frame
Cmax, AUC,AUMCTimepoint: 0.0,0.5,1.0,1.5,2.0.2.5,3.0, 4.0,6.0,8,12,24.0 Hours

Secondary

MeasureTime frame
Adeverse events and Safety assessmentsTimepoint: 0.0,0.5,1.0,1.5,2.0.2.5,3.0, 4.0,6.0,8,12,24.0 Hours

Countries

India

Contacts

Public ContactJestin V Thomas

Akay Flavours and Aromatics Private Limited

Krishnakumar.IM@akay-group.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026